Article
The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
American journal of hypertension - 1 Jul 2008
Kurland Lisa, Hallberg Pär, Melhus Håkan, Liljedahl Ulrika, Hashemi Nashmil, Syvänen Ann-Christine, Lind Lars, Kahan Thomas
Abstract excerpt
BACKGROUND: The aim of this study was to investigate the effect of the plasma concentration of irbesartan, a specific angiotensin II type 1 receptor (AT1R) antagonist, and the blood pressure response in relation to AT1R gene polymorphisms. METHODS: Plasma irbesartan was analyzed in 42 patients with mild-to-moderate hypertension and left ventricular hypertrophy from the Swedish Irbesartan Left Ventricular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
